Novel xanthine oxidase inhibitors as a therapeutic agent or a preventive agent for gout and hyperuricemia

被引：0
|
作者：
Kawana, Asahi [1 ]
Kanazawa, Chikashi [1 ]
Takahashi, Yoshimasa [1 ]
Muroga, Yumiko [1 ]
Imazeki, Mariko [1 ]
Nakada, Yoshio [1 ]
机构：
[1] Teijin Pharma Ltd, Hino, Tokyo, Japan
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
139
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TMX-67, a novel xanthine oxidase/xanthine dehydrogenase (XOD) inhibitor, shows strong uric acid lowering action in patients with hyperuricemia and gout.
    Ishiwata, Y
    Kubo, J
    Komoriya, K
    Yamanaka, H
    Kamatani, N
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S129 - S129
  • [22] Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: A Cohort Study
    Kim, Seoyoung C.
    Schneeweiss, Sebastian
    Choudhry, Niteesh
    Liu, Jun
    Glynn, Robert J.
    Solomon, Daniel H.
    AMERICAN JOURNAL OF MEDICINE, 2015, 128 (06): : 653.e7 - 653.e16
  • [23] Investigation of pyrimidine analogues as xanthine oxidase inhibitors to treat of hyperuricemia and gout through combined QSAR techniques, molecular docking and molecular dynamics simulations
    Abdizadeh, Rahman
    Heidarian, Esfandiar
    Hadizadeh, Farzin
    Abdizadeh, Tooba
    JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2020, 113 : 72 - 100
  • [24] Comparison of the effects of xanthine oxidase inhibitor, allopurinol, and uricosuric agent, benzbromarone, on clinical outcome in patients with chronic heart failure and hyperuricemia
    Yamada, T
    Misaki, N
    Asai, M
    Makino, N
    Kioka, H
    Tsukamoto, Y
    Tamaki, S
    Masuda, M
    Matsumoto, T
    Okuda, K
    Fukunami, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 147A - 147A
  • [25] Long-term safety and efficacy of febuxostat, a novel non-purine selective inhibitor of xanthine oxidase, in subjects with hyperuricemia and gout
    Schumacher, HR
    Wortmann, R
    Becker, M
    MacDonald, P
    Palo, W
    Streit, J
    Lademacher, C
    Joseph-Ridge, N
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 498 - 498
  • [26] Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies
    Saag, Kenneth G.
    Dalbeth, Nicola
    Hsu, Chi-yuan
    Kuo, Chang-Fu
    Nuki, George
    Perez-Ruiz, Fernando
    White, William B.
    Hariri, Ali
    Lee, Yunjung
    Jang, Younghwan
    Han, Song
    Choi, Hyon K.
    CONTEMPORARY CLINICAL TRIALS, 2025, 151
  • [27] Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia
    Kohagura, Kentaro
    Tana, Takeshi
    Higa, Akira
    Yamazato, Masanobu
    Ishida, Akio
    Nagahama, Kazufumi
    Sakima, Atsushi
    Iseki, Kunitoshi
    Ohya, Yusuke
    HYPERTENSION RESEARCH, 2016, 39 (08) : 593 - 597
  • [28] Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia
    Kentaro Kohagura
    Takeshi Tana
    Akira Higa
    Masanobu Yamazato
    Akio Ishida
    Kazufumi Nagahama
    Atsushi Sakima
    Kunitoshi Iseki
    Yusuke Ohya
    Hypertension Research, 2016, 39 : 593 - 597
  • [29] Discovery of Natural Multitarget Xanthine Oxidase Inhibitors for Therapeutic Hyperuricemia Using Virtual Screening, Network Pharmacology and in vitro Experimental Verification
    Cao, Luxi
    Ma, Bei
    Yi, Bingxiang
    Liu, Yaru
    Sun, Jiaying
    CHEMISTRYSELECT, 2023, 8 (30):
  • [30] Lesinurad: A Novel Agent for Management of Chronic Gout
    Haber, Stacy L.
    Fente, Gelila
    Fenton, Skylar N.
    Walker, Elise P.
    Weaver, Brianne M.
    Cano, Alexander J.
    Vu, Katherine
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (07) : 690 - 696
12345